You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 32 No. 10, October 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (84)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Very High Dosage vs Standard Dosage Fluphenazine in Schizophrenia

Frederic Quitkin, MD; Arthur Rifkin, MD; Donald F. Klein, MD

Frederic Quitkin, MD; Arthur Rifkin, MD; Donald F. Klein, MD

Arch Gen Psychiatry. 1975;32(10):1276-1281.


Abstract

• Previous work with chronic schizophrenic patients and a pilot study with nonchronic treatment-refractory schizophrenic patients indicated that very high doses of fluphenazine hydrochloride (1,200 mg/day) have a greater antipsychotic effect than do standard doses. Increased side-effects were not reported. In a double-blind six-week random assignment study, 18 nonchronic treatment-refractory patients received the very high dose and 13 the standard dose.

The standard-dose treated patients had greater improvement on a variety of measures. Analysis of Inpatient Multidimensional Psychiatric Scale scores indicated that some patients taking very high doses had akinesia, an extrapyramidal side-effect that in part accounted for their inferior response.



Author Affiliations

From the Long Island Jewish-Hillside Medical Center, Hillside Division, Glen Oaks, NY.


Footnotes

Accepted for publication Dec 18, 1974

Reprint requests to the Long Island Jewish-Hillside Medical Center, Hillside Division, PO Box 38, Glen Oaks, NY 11004 (Dr Quitkin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lessons From Each Drug Trial
Marder
Am. J. Psychiatry 2007;164:375-376.
FULL TEXT  

Schizophrenia
Kane
NEJM 1996;334:34-42.
FULL TEXT  

Dosage of Haloperidol for Schizophrenia
Rifkin et al.
Arch Gen Psychiatry 1991;48:166-170.
ABSTRACT  

Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Baldessarini et al.
Arch Gen Psychiatry 1988;45:79-91.
ABSTRACT  

High Doses of Haloperidol in Schizophrenia: A Clinical, Biochemical, and Pharmacokinetic Study
Zarifian et al.
Arch Gen Psychiatry 1982;39:212-215.
ABSTRACT  

'Akinetic Depression' in Schizophrenia
Van Putten and May
Arch Gen Psychiatry 1978;35:1101-1107.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.